Terms: = Lung cancer AND TOP2A, TOP2, TP2A AND Treatment
39 results:
1. Exploring effective biomarkers and potential immune related gene in small cell lung cancer.
Yunchu Y; Miyanaga A; Matsuda K; Kamio K; Seike M
Sci Rep; 2024 Mar; 14(1):7604. PubMed ID: 38556560
[TBL] [Abstract] [Full Text] [Related]
2. Predicting potential therapeutic targets and small molecule drugs for early-stage lung adenocarcinoma.
Yu Y; Li L; Luo B; Chen D; Yin C; Jian C; You Q; Wang J; Fang L; Cai D; Sun J
Biomed Pharmacother; 2024 May; 174():116528. PubMed ID: 38555814
[TBL] [Abstract] [Full Text] [Related]
3. Disclosing Potential Therapeutic Targets Associated With Osimertinib Resistance in the Non-small Cell lung cancer Cell Line H1975.
Tong X; Zhang R; Sun R; Yang W; Sun J; Chen J; Li F
Anticancer Res; 2023 Dec; 43(12):5459-5474. PubMed ID: 38030186
[TBL] [Abstract] [Full Text] [Related]
4. Non-small Cell lung cancer Epigenomes Exhibit Altered DNA Methylation in Smokers and Never-smokers.
Karlow JA; Pehrsson EC; Xing X; Watson M; Devarakonda S; Govindan R; Wang T
Genomics Proteomics Bioinformatics; 2023 Oct; 21(5):991-1013. PubMed ID: 37742993
[TBL] [Abstract] [Full Text] [Related]
5. Identification of pivotal genes with prognostic evaluation value in lung adenocarcinoma by bioinformatics analysis.
Wang Y; Wang R; Ma J; Wang T; Ma C; Gu Y; Xu Y; Wang Y
Cell Mol Biol (Noisy-le-grand); 2023 Aug; 69(8):221-225. PubMed ID: 37715381
[TBL] [Abstract] [Full Text] [Related]
6. The role of top2a in immunotherapy and vasculogenic mimicry in non-small cell lung cancer and its potential mechanism.
Wu J; Zhang L; Li W; Wang L; Jia Q; Shi F; Li K; Liao L; Shi Y; Wu S
Sci Rep; 2023 Jul; 13(1):10906. PubMed ID: 37407689
[TBL] [Abstract] [Full Text] [Related]
7. The potential bioactive ingredients and hub genes of five TCM prescriptions against lung adenocarcinoma were explored based on bioinformatics.
Liu T; Wei J
Naunyn Schmiedebergs Arch Pharmacol; 2023 Sep; 396(9):2039-2055. PubMed ID: 36914901
[TBL] [Abstract] [Full Text] [Related]
8. ATM inhibitor KU60019 synergistically sensitizes lung cancer cells to topoisomerase II poisons by multiple mechanisms.
Shu J; Wang X; Yang X; Zhao G
Sci Rep; 2023 Jan; 13(1):882. PubMed ID: 36650267
[TBL] [Abstract] [Full Text] [Related]
9. Genomic Characteristics and the Potential Clinical Implications in Oligometastatic Non-Small Cell lung cancer.
Liao R; Chen K; Li J; He H; Yi G; Huang M; Chen R; Shen L; Zhang X; Xu Z; Yang Z; Peng Y
Cancer Res Treat; 2023 Jul; 55(3):814-831. PubMed ID: 36634615
[TBL] [Abstract] [Full Text] [Related]
10. Diagnosis and Prognosis of Non-small Cell lung cancer based on Machine Learning Algorithms.
Zhou Y; Dong Y; Sun Q; Fang C
Comb Chem High Throughput Screen; 2023; 26(12):2170-2183. PubMed ID: 36627791
[TBL] [Abstract] [Full Text] [Related]
11. Identification of Signal Pathways and Hub Genes of Pulmonary Arterial Hypertension by Bioinformatic Analysis.
Wei RQ; Zhang WM; Liang Z; Piao C; Zhu G
Can Respir J; 2022; 2022():1394088. PubMed ID: 36072642
[TBL] [Abstract] [Full Text] [Related]
12. Identification of a five genes prognosis signature for triple-negative breast cancer using multi-omics methods and bioinformatics analysis.
Ma J; Chen C; Liu S; Ji J; Wu D; Huang P; Wei D; Fan Z; Ren L
Cancer Gene Ther; 2022 Nov; 29(11):1578-1589. PubMed ID: 35474355
[TBL] [Abstract] [Full Text] [Related]
13. [Screening of differentially expressed genes for colorectal cancer and prediction of potential traditional Chinese medicine: based on bioinformatics].
Yun ZJ; Wang HJ; Yu YX; Sun ZY; Yao SK
Zhongguo Zhong Yao Za Zhi; 2022 Mar; 47(6):1666-1676. PubMed ID: 35347966
[TBL] [Abstract] [Full Text] [Related]
14. Bioinformatics study on genes related to a high-risk postoperative recurrence of lung adenocarcinoma.
Lin X; Zhou M; Xu Z; Chen Y; Lin F
Sci Prog; 2021; 104(3):368504211018053. PubMed ID: 34304612
[TBL] [Abstract] [Full Text] [Related]
15. Pericentromeric Satellite III transcripts induce etoposide resistance.
Kanne J; Hussong M; Isensee J; Muñoz-López Á; Wolffgramm J; Heß F; Grimm C; Bessonov S; Meder L; Wang J; Reinhardt HC; Odenthal M; Hucho T; Büttner R; Summerer D; Schweiger MR
Cell Death Dis; 2021 May; 12(6):530. PubMed ID: 34031359
[TBL] [Abstract] [Full Text] [Related]
16. Integration of transcriptomics and metabolomics reveals anlotinib-induced cytotoxicity in colon cancer cells.
Jia Z; Zhang Z; Tian Q; Wu H; Xie Y; Li A; Zhang H; Yang Z; Zhang X
Gene; 2021 Jun; 786():145625. PubMed ID: 33798683
[TBL] [Abstract] [Full Text] [Related]
17. Identification of differentially expressed genes associated with lung adenocarcinoma via bioinformatics analysis.
Yang X; Feng Q; Jing J; Yan J; Zeng Z; Zheng H; Cheng X
Gen Physiol Biophys; 2021 Jan; 40(1):31-48. PubMed ID: 33655889
[TBL] [Abstract] [Full Text] [Related]
18. Identification of potential target genes and crucial pathways in small cell lung cancer based on bioinformatic strategy and human samples.
Chen X; Wang L; Su X; Luo SY; Tang X; Huang Y
PLoS One; 2020; 15(11):e0242194. PubMed ID: 33186389
[TBL] [Abstract] [Full Text] [Related]
19. The Indenoisoquinoline LMP517: A Novel Antitumor Agent Targeting both TOP1 and top2.
Marzi L; Sun Y; Huang SN; James A; Difilippantonio S; Pommier Y
Mol Cancer Ther; 2020 Aug; 19(8):1589-1597. PubMed ID: 32430490
[TBL] [Abstract] [Full Text] [Related]
20. Identification of lung adenocarcinoma biomarkers based on bioinformatic analysis and human samples.
Dong S; Men W; Yang S; Xu S
Oncol Rep; 2020 May; 43(5):1437-1450. PubMed ID: 32323809
[TBL] [Abstract] [Full Text] [Related]
[Next]